drugset / Trial / NCT02695732
The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
Phase 4
Unknown
792 enrolled
Shanghai Zhongshan Hospital
Eastern Hepatobiliary Surgery Hospital · collabGongli Hospital, School of Medicine, The Second Military Medical University · collabShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collabShanghai Public Health Clinical Center · collabShuGuang Hospital · collabXinhua Hospital, Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety of Carvedilol and endoscopic therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding.
Timeline
- Start
- 2015-12
- Primary completion
- 2018-09
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 12.5 mg | Oral |